Literature DB >> 11854615

Pancreatic cell lines: a review.

Alexis B Ulrich1, Bruno M Schmied, Jens Standop, Matthias B Schneider, Parviz M Pour.   

Abstract

Pancreatic cancer has an extremely poor prognosis and lacks early diagnostic and therapeutic possibilities, mainly because of its silent course and explosive fatal outcome. The histogenesis of the disease and early biochemical and genetic alterations surrounding carcinogenesis are still controversial. In vitro studies offer a useful tool to study physiologic, pathophysiologic, differentiation, and transformation processes of cells and to understand some of these shortcomings. The extreme difficulties in isolating individual pancreatic cells and their purification by maintaining their native characteristics have limited research in this area. This review is intended to present and discuss the current availability of rodent and pancreatic cell lines, their differences as well as the difficulties, limitations, and characteristics of these cultured cells. Discussed are in vitro models; ductal, islet, and acinar cell culture; cell differentiation; cell transformation, including genetic and chromosomal alterations; as well as tumor cell markers. Also addressed are the advantages and problems associated with the cell culture in humans and rodents. Advancements in tissue culture technique and molecular biology offer steady progress in this important line of research. The improved methods not only promise the establishment of beta-cell cultures for the treatment of diabetes, but also for studying sequential genetic alterations during pancreatic carcinogenesis and in understanding the tumor cell origin.

Entities:  

Mesh:

Year:  2002        PMID: 11854615     DOI: 10.1097/00006676-200203000-00001

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  12 in total

1.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

Review 2.  Tissue engineering approaches to cell-based type 1 diabetes therapy.

Authors:  Luke D Amer; Melissa J Mahoney; Stephanie J Bryant
Journal:  Tissue Eng Part B Rev       Date:  2014-04-22       Impact factor: 6.389

3.  Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines.

Authors:  Jonathan P Celli; Nicolas Solban; Alvin Liang; Stephen P Pereira; Tayyaba Hasan
Journal:  Lasers Surg Med       Date:  2011-09       Impact factor: 4.025

4.  Feeder-cell-independent culture of the pig embryonic stem cell-derived exocrine pancreatic cell line, PICM-31.

Authors:  Neil C Talbot; Amy E Shannon; Caitlin E Phillips; Wesley M Garrett
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-02-13       Impact factor: 2.416

5.  Designing protease sensors for real-time imaging of trypsin activation in pancreatic cancer cells.

Authors:  Ning Chen; Jin Zou; Siming Wang; Yiming Ye; Yun Huang; Giovanni Gadda; Jenny J Yang
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

6.  Pancreatic carcinoma with multilineage (acinar, neuroendocrine, and ductal) differentiation.

Authors:  Kia Newman; Jay Stahl-Herz; Oluyomi Kabiawu; Elliot Newman; Rosemary Wieczorek; Beverly Wang; Zhiheng Pei; Michael Bannan; Peng Lee; Ruliang Xu
Journal:  Int J Clin Exp Pathol       Date:  2009-06-20

7.  A novel dual-color reporter for identifying insulin-producing beta-cells and classifying heterogeneity of insulinoma cell lines.

Authors:  Nan Sook Lee; Joyce G Rohan; Madison Zitting; Sonia Kamath; Andrew Weitz; Arnold Sipos; Paul M Salvaterra; Kouichi Hasegawa; Martin Pera; Robert H Chow
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

8.  Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.

Authors:  Tatyana Kalinina; Cenap Güngör; Sabrina Thieltges; Maren Möller-Krull; Eva Maria Murga Penas; Daniel Wicklein; Thomas Streichert; Udo Schumacher; Viacheslav Kalinin; Ronald Simon; Benjamin Otto; Judith Dierlamm; Heidi Schwarzenbach; Katharina E Effenberger; Maximilian Bockhorn; Jakob R Izbicki; Emre F Yekebas
Journal:  BMC Cancer       Date:  2010-06-16       Impact factor: 4.430

9.  Chmp 1A is a mediator of the anti-proliferative effects of all-trans retinoic acid in human pancreatic cancer cells.

Authors:  Jing Li; Brandon Orr; Kayla White; Natalia Belogortseva; Richard Niles; Goran Boskovic; Hanh Nguyen; Ava Dykes; Maiyon Park
Journal:  Mol Cancer       Date:  2009-02-12       Impact factor: 27.401

10.  Establishment and characterization of a highly tumourigenic and cancer stem cell enriched pancreatic cancer cell line as a well defined model system.

Authors:  Johannes Fredebohm; Michael Boettcher; Christian Eisen; Matthias M Gaida; Anette Heller; Shereen Keleg; Jörg Tost; Karin M Greulich-Bode; Agnes Hotz-Wagenblatt; Mark Lathrop; Nathalia A Giese; Jörg D Hoheisel
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.